Annexe B: Examen et recommandations sur la fin de l’isolement

Références

• Christof C, Nußbaumer-Streit B, Gartlehner G. WHO guidelines on tuberculosis infection prevention and control. Gesundheitswesen. 2020;82(11):885–889. doi:10.1055/a-1241-4321.
   PubMed Web of Science ®Google Scholar
• Uplekar M, Weil D, Lonnroth K, et al. WHO’s new end TB strategy. In. The Lancet. 2015;385(9979):1799–1801. doi:10.1016/S0140-6736(15)60570-0.
   PubMed Web of Science ®Google Scholar
• Van Cutsem G, Isaakidis P, Farley J, et al. Infection control for drug-resistant tuberculosis: Early Diagnosis and treatment is the key. Clin Infect Dis. 2016;62(Suppl 3):S238–S243. doi:10.1093/cid/ciw012.
   PubMedGoogle Scholar
• Yuen CM, Amanullah F, Dharmadhikari A, et al. Turning off the tap: Stopping tuberculosis transmission through active case-finding and prompt effective treatment. The Lancet. 2015;386(10010):2334–2343. doi:10.1016/S0140-6736(15)00322-0.
   PubMed Web of Science ®Google Scholar
• Migliori GB, Nardell E, Yedilbayev A, et al. Reducing tuberculosis transmission: A consensus document from the World Health Organization regional office for Europe. Eur Respir J. 2019;53(6):1900391. doi:10.1183/13993003.00391-2019.
   PubMed Web of Science ®Google Scholar
• Petersen E, Khamis F, Migliori GB, et al. De-isolation of patients with pulmonary tuberculosis after start of treatment - clear, unequivocal guidelines are missing. Int J Infect Dis. 2017;56:34–38. doi:10.1016/j.ijid.2017.01.029.
   PubMed Web of Science ®Google Scholar
• Calderwood CJ, Wilson JP, Fielding KL, et al. Dynamics of sputum conversion during effective tuberculosis treatment: A systematic review and meta-analysis. PLoS Med . 2021;18(4):e1003566 doi:10.1371/journal.pmed.1003566.
   PubMed Web of Science ®Google Scholar
• Iseman MD. An unholy trinity-three negative sputum smears and release from tuberculosis isolation. Clin Infect Dis. 1997;25(3):671–672. doi:10.1086/513774.
   PubMed Web of Science ®Google Scholar
• Jensen PA, Lambert LA, Iademarco MF, Ridzon R. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. Morbidity and Mortality Weekly Report. Recommendations and Reports/Centers for Disease Control and Prevention. 2005;54(RR17):1–141.
   PubMedGoogle Scholar
• Long R, Bochar K, Chomyc S, et al. Relative versus absolute noncontagiousness of respiratory tuberculosis on treatment. Infect Control Hosp Epidemiol. 2003;24(11):831–838. doi:10.1086/502145.
   PubMed Web of Science ®Google Scholar
• Riley RL, Mills CC, O’Grady F, et al. Infectiousness of air from a tuberculosis ward. Ultraviolet irradiation of infected air: comparative infectiousness of different patients. Am Rev Respir Dis. 1962;85(9):511–525. doi:10.1164/arrd.1962.85.4.511.
   PubMedGoogle Scholar
• Kamat SR, Dawson JJY, Devadatta S, et al. A controlled study of the influence of segregation of tuberculous patients for one year on the attack rate of tuberculosis in a 5-year period in close family contacts in South India. Bulletin of the World Health Organization. 1998;76(2):109–124.
   PubMed Web of Science ®Google Scholar
• Devadatta S, Dawson JJ, Fox W, et al. Attack rate of tuberculosis in a 5-year period among close family contacts of tuberculous patients under domiciliary treatment with isoniazid plus PAS or isoniazid alone. Bull World Health Organ. 1970;42(3):337–351.
   PubMed Web of Science ®Google Scholar
• Rouillon A, Perdrizet S, Parrot R. Transmission of tubercle bacilli: the effects of chemotherapy. Tubercle. 1976;57(4):275–299. doi:10.1016/S0041-3879(76)80006-2.
   PubMedGoogle Scholar
• Dharmadhikari AS, Nardell E. Serial acid fast bacilli smear and culture conversion rates over 26 weeks in a cohort of 93 sputum culture–positive tuberculosis (TB). Clin Infect Dis. 2011;52(4):554–556. doi:10.1093/cid/ciq182.
   PubMedGoogle Scholar
• Johnston RF, Wildrick KH. The impact of chemotherapy on the care of patients with tuberculosis. Am Rev Respir Dis. 1974;109(6):636–664. doi:10.1164/arrd.1974.109.6.636.
   PubMedGoogle Scholar
• Menzies D. Effect of treatment on contagiousness of patients with active pulmonary tuberculosis. Infect Control Hosp Epidemiol. 1997;18(8):582–586. doi:10.1086/647678.
   PubMed Web of Science ®Google Scholar
• Noble RC. Infectiousness of pulmonary tuberculosis after starting chemotherapy: Review of the available data on an unresolved question. American Journal of Infection Control. 1981;9(1):6–10. doi:10.1016/S0196-6553(81)80003-X.
   Web of Science ®Google Scholar
• Gunnels JJ, Bates JH, Swindoll H. Infectivity of sputum-positive tuberculous patients on chemotherapy. Am Rev Respir Dis. 1974;109(3):323–330. doi:10.1164/arrd.1974.109.3.323.
   PubMedGoogle Scholar
• Riley RL, Moodie AS. Infectivity of patients with pulmonary tuberculosis in inner city homes. Am Rev Respir Dis. 1974;110(6):810–812. doi:10.1164/arrd.1974.110.6P1.810.
   PubMedGoogle Scholar
• Brooks SM, Lassiter NL, Young EC. A pilot study concerning the infection risk of sputum positive tuberculosis patients on chemotherapy. Am Rev Respir Dis. 1973;108(4):799–804. doi:10.1164/arrd.1973.108.4.799.
   PubMedGoogle Scholar
• Karat AS, Gregg M, Barton HE, et al. Evidence for the use of triage, respiratory isolation, and effective treatment to reduce the transmission of mycobacterium tuberculosis in healthcare set-tings: A systematic review. Clin Infect Dis. 2021;72(1):155–172. doi:10.1093/cid/ciaa720.
   PubMed Web of Science ®Google Scholar
• Schmidt BM, Engel ME, Abdullahi L, Ehrlich R. Effectiveness of control measures to prevent occupational tuberculosis infection in health care workers: A systematic review. BMC Public Health. 2018;18(1):1–12. doi:10.1186/s12889-018-5518-2.
   Google Scholar
• Riley RL. Aerial dissemination of pulmonary tuberculosis. Am Rev Tuberc. 1957;76(6):931–941. doi:10.1164/artpd.1957.76.6.931.
   PubMedGoogle Scholar
• Dharmadhikari AS, Mphahlele M, Venter K, et al. Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2014;18(9):1019–1025. doi:10.5588/ijtld.13.0834.
   PubMed Web of Science ®Google Scholar
• Escombe AR, Moore DAJ, Gilman RH, et al. The infectiousness of tuberculosis patients coinfected with HIV. PLoS Med. 2008;5(9):e188–1396. doi:10.1371/journal.pmed.0050188.
   Web of Science ®Google Scholar
• Escombe AR, Oeser C, Gilman RH, et al. The detection of airborne transmission of tuberculosis from HIV-infected patients, using an in vivo air sampling model. Clin Infect Dis. 2007; 44(10):1349–1357. doi:10.1086/515397.
   PubMed Web of Science ®Google Scholar
• Fennelly KP, Martyny JW, Fulton KE, et al. Cough-generated Aerosols of Mycobacterium tuberculosis: A New Method to Study Infectiousness. Am J Respir Crit Care Med. 2004;169(5):604–609. doi:10.1164/rccm.200308-1101OC.
   PubMed Web of Science ®Google Scholar
• Fennelly KP, Jones-López EC, Ayakaka I, et al. Variability of infectious Aerosols produced during Coughing by patients with pulmonary tuberculosis. Am J Respir Crit Care Med. 2012;186(5):450–457. doi:10.1164/rccm.201203-0444OC.
   PubMed Web of Science ®Google Scholar
• Jones-López EC, Acuña-Villaorduña C, Ssebidandi M, et al. Cough Aerosols of mycobacterium tuberculosis in the prediction of incident tuberculosis disease in household contacts. Clin Infect Dis. 2016;63(1):10–20. doi:10.1093/cid/ciw199.
   PubMed Web of Science ®Google Scholar
• Jones-López EC, Namugga O, Mumbowa F, et al. Cough aerosols of Mycobacterium tuberculosis predict new infection: A house- hold contact study. Am J Respir Crit Care Med. 2013;187(9):1007–1015. doi:10.1164/rccm.201208-1422OC.
   PubMed Web of Science ®Google Scholar
• Acuña-Villaorduña C, Ayakaka I, Schmidt-Castellani LG, et al. Host determinants of infectiousness in smear-positive patients with pulmonary tuberculosis. Open Forum Infect Dis. 2019;6(6):ofz184–9. doi:10.1093/ofid/ofz184.
   PubMed Web of Science ®Google Scholar
• Theron G, Limberis J, Venter R, et al. Bacterial and host deter- minants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosis. Nat Med. 2020;26(9):1435–1443. doi:10.1038/s41591-020-0940-2.
   PubMed Web of Science ®Google Scholar
• Jindani A, Aber VR, Edwards EA, Mitchison DA. The early bactericidal activity of drugs in patients with pulmonary tuberculosis. Am Rev Respir Dis. 1980;121(6):939–949. doi:10.1164/arrd.1980.121.6.939.
   PubMed Web of Science ®Google Scholar
• Johnson JL, Hadad DJ, Boom WH, et al. Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxi- floxacin in pulmonary tuberculosis. Int J Tuberc Lung Dis. 2006;10(6):605–612. doi:10.1164/rccm.200806-892OC.
   PubMed Web of Science ®Google Scholar
• Diacon AH, Dawson R, Von Groote-Bidlingmaier F, et al. Randomized dose-ranging study of the 14-day early bactericidal activity of bedaquiline (TMC207) in patients with sputum microscopy smear-positive pulmonary tuberculosis. Antimicrob Agents Chemother. 2013;57(5):2199–2203. doi:10.1128/AAC.02243-12.
   PubMed Web of Science ®Google Scholar
• Diacon AH, De Jager VR, Dawson R, et al. Fourteen-day bactericidal activity, safety, and pharmacokinetics of linezolid in adults with drug-sensitive pulmonary tuberculosis. Antimicrob Agents Chemother. 2020;64(4):e02012–19. doi:10.1128/AAC.02012-19.
   PubMed Web of Science ®Google Scholar
• Gammon J. The psychological consequences of source isolation: A review of the literature. J Clin Nurs. 1999;8(1):13–21. doi:10.1046/j.1365-2702.1999.00201.x.
   PubMed Web of Science ®Google Scholar
• Basham CA, Karim ME, Cook VJ, et al. Tuberculosis-associated depression: a population-based cohort study of people immigrat- ing to British Columbia, Canada, 1985-2015. Ann Epidemiol. 2021;63:7–14. doi:10.1016/j.annepidem.2021.06.002.
   PubMed Web of Science ®Google Scholar
• Sprague E, Reynolds S, Brindley P. Patient isolation precautions: Are they worth it? Can Respir J. 2016; 2016:5352625 doi:10.1155/2016/5352625.
   PubMed Web of Science ®Google Scholar
• Moffatt J, Mayan M, Long R. Sanitoriums and the Canadian colo- nial legacy: The untold experiences of tuberculosis treatment. Qual Health Res. 2013;23(12):1591–1599. doi:10.1177/1049732313508843.
   PubMed Web of Science ®Google Scholar
• Horter S, Stringer B, Reynolds L, et al. "Home is where the patient is": a qualitative analysis of a patient-centred model of care for multi-drug resistant tuberculosis. BMC Health Serv Res. 2014;14:81–88. doi:10.1186/1472-6963-14-81.
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. European union standards for tuberculosis care - 2017 update. Publications Office, 2018. 10.2900/307948.
   Google Scholar
• National Institute for Health and Care Excellence (NICE) -. Tuberculosis: management and infection control in hospital. 2020. Disponible sur: https://pathways.nice.org.uk/pathways/tuberculosis. Consulté le 10 août 2021.
   Google Scholar
• Ministry of Health. New guidelines for tuberculosis control in New Zealand. New Zealand Public Health Report. 1996;3(12):89–91. Disponible sur: http://search.ebscohost.com/login.aspx?di rect=true&db=rzh&AN=1998077986&site=ehost-live&scope=site. Consulté le 10 août 2021.
   Google Scholar
• Coulter C, and the National Tuberculosis Advisory Committee. Infection control guidelines for the management of patients with suspected or confirmed pulmonary tuberculosis in healthcare settings. Commun Dis Intell Q Rep. 2016;40(3):E360–E366.
   PubMedGoogle Scholar